Inotropes and Inodilators for Acute Heart Failure

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus

Acute heart failure (AHF) emerges as a major and growing epidemiological concern with high morbidity and mortality rates. Current therapies in patients with acute heart failure rely on different strategies. Patients with hypotension, hypoperfusion, or shock require inotropic support, whereas diuretics and vasodilators are recommended in patients with systemic or pulmonary congestion. Traditiona...

Inotropes – Angina and Heart Failure Management

The inotropic agent in the context of heart failure and angina is classified into positive and negative inotropic agent. The positive agent increases the contractility and will be discussed in detail in this article. A brief about the negative inotropic agent, which decreases the myocardial contractility, is mentioned. The inotropic agent, when mentioned alone without any prefix, stands for a p...

Inotropes – Angina and Heart Failure Management

The inotropic agent in the context of heart failure and angina is classified into positive and negative inotropic agent. The positive agent increases the contractility and will be discussed in detail in this article. A brief about the negative inotropic agent, which decreases the myocardial contractility, is mentioned. The inotropic agent, when mentioned alone without any prefix, stands for a p...

Therapy of Congestive Heart Failure in Dogs with Inodilators

Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.

INTRODUCTION Cardiorenal syndrome (CRS) is common in acute heart failure (AHF), and is associated with dire prognosis. Levosimendan, a positive inotrope that also has diuretic effects, may improve patients' renal profile. Published results are conflicting. OBJECTIVES We aimed to assess the incidence of CRS in AHF patients according to the inotrope used and to determine its predictors in order...